Balanites aegyptiaca dates hydroethanolic extract shows anti-neurodegenerative effect in diabetes-mediated neurodegenerative disorders in rats. | ||||
| Egyptian Journal of Chemistry | ||||
| Volume 67, Issue 4, April 2024, Page 559-576 PDF (11.58 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejchem.2023.231893.8501 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Abeer Y Ibrahim1; Nermeen M. Shaffie2; Samah A El-Newary   3
| ||||
| 1Department of Medicinal and Aromatic Plants Research, Pharmaceutical and Drug Industries Division, National Research Centre, Dokki, Cairo, Egypt | ||||
| 2National Research Centre | ||||
| 3Medicinal and Aromatic Plants Research Department, National Research Centre | ||||
| Abstract | ||||
| Type-3 diabetes has been suggested for Alzheimer’s disease because of its similarities in molecular and cellular characteristics to type-1 and type-2 diabetes, insulin resistance related to memory impairment, and cognitive defects in elderly people. This study aimed to evaluate the potential application of Balanites aegyptiaca date hydroethanolic extract in treating diabetes-mediated neurodegenerative disorders in rats. Neurodegenerative disorders in diabetic male albino Wister rats were studied using a streptozotocin (STZ, 65 mg/kg body wt.) model. Rats orally received Balanites at 2250 mg/kg body wt. as ¼ LD50 for three months. Four groups were randomly organized: negative control, STZ control, extract control, and treated group. Results showed that the blood glucose level was reduced from 354.24±4.52 mg/dL (STZ group) to 115±4.92 mg/dL (treated group), which indicated that Balanites exhibited an anti-diabetic effect. Concomitantly, insulin significantly elevated (53.00% and 392.50%) compared with the STZ group (P≤ 0.001) after 45 and 90 days, respectively, with hypolipidemic action. Compared with the STZ group (P≤ 0.001), Balanites exerted a neurodegenerative repairing effect, as it significantly inhibited acetylcholinesterase (36.84% and 52.85%) based on acetylcholine content augmentation (28.40% and 53.14%) at the two follow-ups. In addition, Balanites ameliorated apoptosis, inflammation, oxidative stress, and neurotrophic factor in the brain. Brain sections showed no amyloid-beta plaque and neurofibrillary tangles that were recorded for the STZ group. Finally, Balanites addressed diabetes-induced neurodegenerative disorders in rats because of its orchestral approach mechanisms on acetylcholinesterase, amyloid-beta, neurofibrillary tangles, apoptosis, neuroinflammation, and oxidative stress. Therefore, this study could be considered for clinical trials. | ||||
| Keywords | ||||
| Diabetes-induced neurodegenerative disorders; Acetylcholine esterase; Amyloid-beta; Neurofibrillary tangles; Brain-derived neurotrophic factor (BDFN); Bcl-2 | ||||
|
Statistics Article View: 297 PDF Download: 191 |
||||
